Herrington DM - Search Results

1

Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA).

Shah SA, Herrington DM, Howard TD, Divers J, Arnett DK, Burke GL, Kao WH, Guo X, Siscovick DS, Chakravarti A, Lima JA, Psaty BM, Tomaselli GF, Rich SS, Bowden DW, Post W. Shah SA, et al. Among authors: herrington dm. Ann Noninvasive Electrocardiol. 2013 Jan;18(1):29-40. doi: 10.1111/anec.12028. Ann Noninvasive Electrocardiol. 2013. PMID: 23347024 Free PMC article.

2

Are drugs within a class interchangeable?

Furberg CD, Herrington DM, Psaty BM. Furberg CD, et al. Among authors: herrington dm. Lancet. 1999 Oct 2;354(9185):1202-4. doi: 10.1016/S0140-6736(99)03190-6. Lancet. 1999. PMID: 10513728 Review. No abstract available.

3

Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter.

Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, Burke GL, McBurnie MA, Morgan TM, Espeland MA. Herrington DM, et al. J Cardiovasc Risk. 2001 Oct;8(5):319-28. doi: 10.1177/174182670100800512. J Cardiovasc Risk. 2001. PMID: 11702039

4

Estrogen replacement and brachial artery flow-mediated vasodilation in older women.

Herrington DM, Espeland MA, Crouse JR 3rd, Robertson J, Riley WA, McBurnie MA, Burke GL. Herrington DM, et al. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1955-61. doi: 10.1161/hq1201.100241. Arterioscler Thromb Vasc Biol. 2001. PMID: 11742870

5

Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.

Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA, Bleecker ER. Herrington DM, et al. N Engl J Med. 2002 Mar 28;346(13):967-74. doi: 10.1056/NEJMoa012952. N Engl J Med. 2002. PMID: 11919305 Free article. Clinical Trial.

6

Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.

Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Meyers DA, Bleecker ER. Herrington DM, et al. Circulation. 2002 Apr 23;105(16):1879-82. doi: 10.1161/01.cir.0000016173.98826.88. Circulation. 2002. PMID: 11997270 Clinical Trial.

7

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.

Herrington DM, Vittinghoff E, Howard TD, Major DA, Owen J, Reboussin DM, Bowden D, Bittner V, Simon JA, Grady D, Hulley SB. Herrington DM, et al. Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1012-7. doi: 10.1161/01.atv.0000018301.91721.94. Arterioscler Thromb Vasc Biol. 2002. PMID: 12067913

8

From presumed benefit to potential harm--hormone therapy and heart disease.

Herrington DM, Howard TD. Herrington DM, et al. N Engl J Med. 2003 Aug 7;349(6):519-21. doi: 10.1056/NEJMp038108. N Engl J Med. 2003. PMID: 12904515 No abstract available.

9

Racial differences in endothelial function in postmenopausal women.

Loehr LR, Espeland MA, Sutton-Tyrrell K, Burke GL, Crouse JR 3rd, Herrington DM. Loehr LR, et al. Among authors: herrington dm. Am Heart J. 2004 Oct;148(4):606-11. doi: 10.1016/j.ahj.2004.04.032. Am Heart J. 2004. PMID: 15459590

10

beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study.

Hindorff LA, Heckbert SR, Psaty BM, Lumley T, Siscovick DS, Herrington DM, Edwards KL, Tracy RP. Hindorff LA, et al. Among authors: herrington dm. Am J Hypertens. 2005 Mar;18(3):392-7. doi: 10.1016/j.amjhyper.2004.10.014. Am J Hypertens. 2005. PMID: 15797659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

439 results

Search Page